58 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
AMPH Amphastar Pharmaceuticals, Inc. $18.33 $847.88M N/A
Article Searches
Amphastar Pharmaceuticals' (AMPH) CEO Yongfeng Zhang on Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4155751-amphastar-pharmaceuticals-amph-ceo-yongfeng-zhang-q4-2017-results-earnings-call-transcript?source=feed_sector_healthcare Mar 12, 2018 - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2017 Earnings Conference Call March 12, 2018, 17:00 ET Executives Jason Shandell - President William Peters - CFO Yongfeng Zhang - CEO Analysts David A
M&A, Innovation & New Drugs to Drive Pharma Stocks http://www.zacks.com/commentary/152408/ma-innovation-new-drugs-to-drive-pharma-stocks?cid=CS-ZC--152408 Mar 08, 2018 - M&A, Innovation & New Drugs to Drive Pharma Stocks
Mallinckrodt PLC (MNK) Jumps: Stock Rises 15.3% http://www.zacks.com/stock/news/294063/mallinckrodt-plc-mnk-jumps-stock-rises-153?cid=CS-ZC--294063 Feb 28, 2018 - Mallinckrodt PLC (MNK) shares rose more than 15% in the last trading session, amid huge volumes.
Key Factors to Influence Penumbra's (PEN) Earnings in Q4 http://www.zacks.com/stock/news/293085/key-factors-to-influence-penumbras-pen-earnings-in-q4?cid=CS-ZC-FT-293085 Feb 21, 2018 - Penumbra (PEN) expects to gain from solid performance by neuro and peripheral vascular arms in Q4. Strong growth across all geographies is likely to drive the top line.
What's in Store for Veeva Systems (VEEV) in Q4 Earnings? http://www.zacks.com/stock/news/293083/whats-in-store-for-veeva-systems-veev-in-q4-earnings?cid=CS-ZC-FT-293083 Feb 21, 2018 - Consistent focus on Subscription Services is likely to drive Veeva Systems (VEEV) in Q4.
Is a Beat in Store for Inogen (INGN) This Earnings Season? http://www.zacks.com/stock/news/293072/is-a-beat-in-store-for-inogen-ingn-this-earnings-season?cid=CS-ZC-FT-293072 Feb 21, 2018 - Strong product portfolio and a unique direct-to-consumer business model are expected to drive Inogen (INGN) in Q4.
Can PBM Unit Drive Express Scripts' (ESRX) Earnings in Q4? http://www.zacks.com/stock/news/293001/can-pbm-unit-drive-express-scripts-esrx-earnings-in-q4?cid=CS-ZC-FT-293001 Feb 20, 2018 - Express Scripts (ESRX) expects Q4 results to show earnings growth on strength in PBM segment.
5 Reasons to Invest in PerkinElmer (PKI) Stock Right Now http://www.zacks.com/stock/news/292268/5-reasons-to-invest-in-perkinelmer-pki-stock-right-now?cid=CS-ZC-FT-292268 Feb 13, 2018 - PerkinElmer (PKI) rides on synergies from the acquisition of EUROIMMUN and broadened product base.
Henry Schein (HSIC) Q4 Earnings to Show Growth in All Lines? http://www.zacks.com/stock/news/292126/henry-schein-hsic-q4-earnings-to-show-growth-in-all-lines?cid=CS-ZC-FT-292126 Feb 12, 2018 - Henry Schein (HSIC) likely to gain on strength across all business segments in Q4.
Will Global Industrial Unit Aid Ecolab (ECL) in Q4 Earnings? http://www.zacks.com/stock/news/292162/will-global-industrial-unit-aid-ecolab-ecl-in-q4-earnings?cid=CS-ZC-FT-292162 Feb 12, 2018 - Ecolab's (ECL) strong segmental sales and acquisition-driven strategies are likely to drive fourth-quarter results.

Pages: 123456

<<<Page 4>